{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:12:21Z","timestamp":1790305941706,"version":"4.1.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T00:00:00Z","timestamp":1678752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>In our latest research, we have demonstrated that the recipient parasylvian cortical arteries (PSCAs) with hemodynamic sources from the middle cerebral artery (M-PSCAs) has a higher risk of postoperative cerebral hyperperfusion (CHP) syndrome than those from non-M-PSCAs in adult moyamoya disease (MMD) patient. However, whether there are differences between M-PSCAs and non-M-PSCAs in vascular specimens characteristics has not been studied. In this study, we further investigate the vascular specimen of recipient PSCAs by histological and immunohistochemical methods.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>50 vascular specimens of recipient PSCAs were obtained from 50 adult MMD patients during the combined bypass surgeries in our departments of Zhongnan hospital. 4 recipient PSCAs samples were also obtained in the same way from the middle cerebral artery occlusion patients. The samples were received the pathological sectioning, hematoxylin and eosin staining, and immunohistochemistry, then the vascular wall thickness, matrix metalloproteinase-9 (MMP-9) and hypoxia-inducing factor-1<jats:italic>\u03b1<\/jats:italic> (HIF-1<jats:italic>\u03b1<\/jats:italic>) were analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>M-PSCAs adult MMD patients had a thinner intima than non-M-PSCAs in the recipient PSCAs specimens. In recipient non-M-PSCAs vascular specimens, the immunoreactivity indicating HIF-1<jats:italic>\u03b1<\/jats:italic> and matrix metalloproteinase-9 (MMP-9) was significantly higher than M-PSCAs groups. The logistic regression analyses showed that the M-PSCAs was an independent risk factor of postoperative cerebral hyperperfusion (CHP) syndrome (OR 6.235, 95% CI1.018-38.170, <jats:italic>P<\/jats:italic>\u2009=\u20090.048) in MMD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our results indicate that M-PSCAs adult MMD patients had thinner intima than non-MCAs adult MMD patients in the PSCAs. More importantly, HIF-1<jats:italic>\u03b1<\/jats:italic> and MMP-9 were overexpressed in non-M-PSCAs vascular specimens.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fsurg.2023.1080395","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T04:41:59Z","timestamp":1678768919000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Expression of hypoxia-inducing factor-1\u03b1 and matrix metalloproteinase-9 in the recipient parasylvian cortical arteries with different hemodynamic sources in adult moyamoya disease"],"prefix":"10.3389","volume":"10","author":[{"given":"Mingrui","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianshu","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiping","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jincao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/archneur.1969.00480090076012","article-title":"Cerebrovascular \u201cmoyamoya\u201d disease. Disease showing abnormal net-like vessels in base of brain","volume":"20","author":"Suzuki","year":"1969","journal-title":"Arch Neurol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.5853\/jos.2015.01627","article-title":"Moyamoya disease: epidemiology, clinical features, and diagnosis","volume":"18","author":"Kim","year":"2016","journal-title":"J Stroke"},{"key":"B3","doi-asserted-by":"publisher","first-page":"793","DOI":"10.3171\/2016.11.JNS161688","article-title":"Meta-analysis of the surgical outcomes of symptomatic moyamoya disease in adults","volume":"128","author":"Jeon","year":"2018","journal-title":"J Neurosurg"},{"key":"B4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1161\/STROKEAHA.115.010819","article-title":"Significance of the hemorrhagic site for recurrent bleeding: prespecified analysis in the Japan adult moyamoya trial","volume":"47","author":"Takahashi","year":"2016","journal-title":"Stroke"},{"key":"B5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.surneu.2007.07.077","article-title":"Delayed intracerebral hemorrhage after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease: possible involvement of cerebral hyperperfusion and increased vascular permeability","volume":"71","author":"Fujimura","year":"2009","journal-title":"Surg Neurol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3171\/2019.10.JNS191207","article-title":"Hemodynamic analysis of the recipient parasylvian cortical arteries for predicting postoperative hyperperfusion during STA-MCA bypass in adult patients with moyamoya disease","volume":"134","author":"Zhang","year":"2019","journal-title":"J Neurosurg"},{"key":"B7","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2176\/nmc.oa.2016-0031","article-title":"Histopathological characteristics of distal middle cerebral artery in adult and pediatric patients with moyamoya disease","volume":"56","author":"Takagi","year":"2016","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s11596-016-1677-5","article-title":"Histopathological features of middle cerebral artery and superficial temporal artery from patients with moyamoya disease and enlightenments on clinical treatment","volume":"36","author":"Sun","year":"2016","journal-title":"J Huazhong Univ Sci Technol Med Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2176\/nmc.52.245","article-title":"Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis)","volume":"52","year":"2012","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1440-1789.2004.00550.x","article-title":"Pathological and immunohistochemical findings of an autopsy case of adult moyamoya disease","volume":"24","author":"Takekawa","year":"2004","journal-title":"Neuropathology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1179\/1743132814Y.0000000432","article-title":"Quantitative analysis of early postoperative cerebral blood flow contributes to the prediction and diagnosis of cerebral hyperperfusion syndrome after revascularization surgery for moyamoya disease","volume":"37","author":"Fujimura","year":"2015","journal-title":"Neurol Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e774","DOI":"10.1016\/j.wneu.2018.07.266","article-title":"Intracranial hemorrhage after superficial temporal artery-middle cerebral artery direct anastomosis for adults with moyamoya disease","volume":"119","author":"Park","year":"2018","journal-title":"World Neurosurg"},{"key":"B13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.5853\/jos.2015.01739","article-title":"Moyamoya disease: treatment and outcomes","volume":"18","author":"Kim","year":"2016","journal-title":"J Stroke"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1097\/01.TP.0000063128.86981.B2","article-title":"Expression of transforming growth factor-beta1 and hypoxia-inducible factor-1alpha in an experimental model of kidney transplantation","volume":"75","author":"Lario","year":"2003","journal-title":"Transplantation"},{"key":"B15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1096\/fj.01-0496fje","article-title":"Physiologically low oxygen concentrations in fetal skin regulate hypoxia-inducible factor 1 and transforming growth factor-beta3","volume":"16","author":"Scheid","year":"2002","journal-title":"FASEB J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.apsb.2015.05.007","article-title":"HIF-1alpha pathway: role, regulation and intervention for cancer therapy","volume":"5","author":"Masoud","year":"2015","journal-title":"Acta Pharm Sin B"},{"key":"B17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1152\/physiol.00016.2008","article-title":"Brain protection by erythropoietin: a manifold task","volume":"23","author":"Rabie","year":"2008","journal-title":"Physiology (Bethesda)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s10571-012-9803-9","article-title":"Hypoxia inducible factor-1: its potential role in cerebral ischemia","volume":"32","author":"Singh","year":"2012","journal-title":"Cell Mol Neurobiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"5614","DOI":"10.1166\/jnn.2014.8728","article-title":"Hypoxia-inducible factor-1alpha and erythropoietin expression in the hippocampus of neonatal rats following hypoxia-ischemia","volume":"14","author":"Lu","year":"2014","journal-title":"J Nanosci Nanotechnol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.nbd.2016.03.018","article-title":"Neuronal deficiency of HIF prolyl 4-hydroxylase 2 in mice improves ischemic stroke recovery in an HIF dependent manner","volume":"91","author":"Li","year":"2016","journal-title":"Neurobiol Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"801985","DOI":"10.3389\/fimmu.2021.801985","article-title":"Biological functions and regulatory mechanisms of hypoxia-inducible factor-1alpha in ischemic stroke","volume":"12","author":"He","year":"2021","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"8922","DOI":"10.1523\/JNEUROSCI.22-20-08922.2002","article-title":"Activation of hypoxia-inducible factor-1 in the rat cerebral cortex after transient global ischemia: potential role of insulin-like growth factor-1","volume":"22","author":"Chavez","year":"2002","journal-title":"J Neurosci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.mam.2008.05.002","article-title":"Progress in matrix metalloproteinase research","volume":"29","author":"Murphy","year":"2008","journal-title":"Mol Aspects Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/bs.apha.2017.08.002","article-title":"Matrix metalloproteinases, vascular remodeling, and vascular disease","volume":"81","author":"Wang","year":"2018","journal-title":"Adv Pharmacol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1002\/jcp.22175","article-title":"Expression profiling of ETS and MMP factors in VEGF-activated endothelial cells: role of MMP-10 in VEGF-induced angiogenesis","volume":"224","author":"Heo","year":"2010","journal-title":"J Cell Physiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"C92","DOI":"10.1152\/ajpcell.00346.2018","article-title":"Piezo1 mediates angiogenesis through activation of MT1-MMP signaling","volume":"316","author":"Kang","year":"2019","journal-title":"Am J Physiol Cell Physiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ijbiomac.2020.10.129","article-title":"Promote anti-inflammatory and angiogenesis using a hyaluronic acid-based hydrogel with miRNA-laden nanoparticles for chronic diabetic wound treatment","volume":"166","author":"Yang","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"11391","DOI":"10.18632\/aging.102537","article-title":"Melatonin protects blood-brain barrier integrity and permeability by inhibiting matrix metalloproteinase-9 via the NOTCH3\/NF-kappaB pathway","volume":"11","author":"Qin","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.surneu.2008.10.009","article-title":"Increased expression of serum matrix metalloproteinase-9 in patients with moyamoya disease","volume":"72","author":"Fujimura","year":"2009","journal-title":"Surg Neurol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1136\/jnnp.2009.191817","article-title":"Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease","volume":"81","author":"Kang","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B31","doi-asserted-by":"publisher","first-page":"721118","DOI":"10.3389\/fneur.2021.721118","article-title":"MMP-9 as a biomarker for predicting hemorrhagic strokes in moyamoya disease","volume":"12","author":"Lu","year":"2021","journal-title":"Front Neurol"}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2023.1080395\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T04:42:01Z","timestamp":1678768921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2023.1080395\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,14]]},"references-count":31,"alternative-id":["10.3389\/fsurg.2023.1080395"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2023.1080395","relation":{},"ISSN":["2296-875X"],"issn-type":[{"value":"2296-875X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,14]]},"article-number":"1080395"}}